Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults

NCT07199933 is registered in ClinicalTrials.gov with Hongyan Wu as lead sponsor.

NCT NCT07199933
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07199933 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Diacerein in the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adults
Lead sponsor
Hongyan Wu
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2025
Completion date
October 31, 2027
Enrollment
74 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

mafld